Jianfeng Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jianfeng Zhao has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Qinghui Fu
The Department of SICU, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2 shared publications - Enjiang Chen
The Department of SICU, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
1 shared publication - Jun Hu
Department of Neurosurgery Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou Zhejiang China
1 shared publication - Junfeng Zhang
Department of Intensive Care Unit, Beilun People’s Hospital, Ningbo, Zhejiang Province, China
1 shared publication - Shi Fu
Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China
1 shared publication - Weina Lu
The Department of SICU, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
1 shared publication
Latest Publications
- Open Access
- 3 January 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (1) , e41216
Identification of potential crucial genes and biomarkers from neutrophils in sepsis using bioinformatics analysis
Sepsis is a complex series of immune responses to infection and is commonly associated with acquired immunodeficiency. The current study aimed to identify the biomarkers of sepsis. Differential expression analysis and protein–protein interaction analysis were conducted to explore potential biomarkers. Gene Ontology enrichment analysis and Kyoto Encyclopedia of Genes and Genomes analysis were performed to explore potential mechanisms. The Immune Cell Abundance Identifier website was utilized to evaluate immune cell infiltration in the whole blood. Receiver operating characteristic curve and area under the curve were applied to compare the prognostic accuracy of hub genes. Six genes were selected via differentially expressed gene analysis and protein–protein interaction analysis. Furthermore, CTSD, GADD45A, MAPK14, MMP9, and VIM were selected via validation analysis of independent datasets. Immune infiltration analysis showed that CTSD, GADD45A, MAPK14, MMP9, and VIM may regulate immune cells via neutrophils. Patients with sepsis had a significantly higher expression of CTSD, GADD45A, MAPK14, MMP9, and VIM than normal health controls. The area under the curve of CTSD, GADD45A, MAPK14, MMP9, and VIM were 0.90 (0.83–0.97), 0.89 (0.81–0.96), 0.91 (0.84–0.87), 0.95 (0.91–1.00), and 0.95 (0.91–1.00), respectively. According to the validation result of RT-PCR, only MAPK14 was significantly upregulated compared with controls, which was concordant with the bioinformatics analysis results. This study identified several potential diagnostic genes including CTSD, GADD45A, MAPK14, MMP9, and VIM. These genes may regulate the expression of immune cells via neutrophils in the development of sepsis.
- 3 January 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (1) , e41216
Open AccessIdentification of potential crucial genes and biomarkers from neutrophils in sepsis using bioinformatics analysis
Sepsis is a complex series of immune responses to infection and is commonly associated with acquired immunodeficiency. The current study aimed to identify the biomarkers of sepsis. Differential expression analysis and protein–protein interaction analysis were conducted to explore potential biomarkers. Gene Ontology enrichment analysis and Kyoto Encyclopedia of Genes and Genomes analysis were performed to explore potential mechanisms. The Immune Cell Abundance Identifier website was utilized to evaluate immune cell infiltration in the whole blood. Receiver operating characteristic curve and area under the curve were applied to compare the prognostic accuracy of hub genes. Six genes were selected via differentially expressed gene analysis and protein–protein interaction analysis. Furthermore, CTSD, GADD45A, MAPK14, MMP9, and VIM were selected via validation analysis of independent datasets. Immune infiltration analysis showed that CTSD, GADD45A, MAPK14, MMP9, and VIM may regulate immune cells via neutrophils. Patients with sepsis had a significantly higher expression of CTSD, GADD45A, MAPK14, MMP9, and VIM than normal health controls. The area under the curve of CTSD, GADD45A, MAPK14, MMP9, and VIM were 0.90 (0.83–0.97), 0.89 (0.81–0.96), 0.91 (0.84–0.87), 0.95 (0.91–1.00), and 0.95 (0.91–1.00), respectively. According to the validation result of RT-PCR, only MAPK14 was significantly upregulated compared with controls, which was concordant with the bioinformatics analysis results. This study identified several potential diagnostic genes including CTSD, GADD45A, MAPK14, MMP9, and VIM. These genes may regulate the expression of immune cells via neutrophils in the development of sepsis.
- Open Access
- 24 March 2022
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 22 (4) , 481-489
Identification of the TF-miRNA-mRNA co-regulatory networks involved in sepsis
Sepsis is a life-threatening medical condition caused by a dysregulated host response to infection. Recent studies have found that the expression of miRNAs is associated with the pathogenesis of sepsis and septic shock. Our study aimed to reveal which miRNAs may be involved in the dysregulated immune response in sepsis and how these miRNAs interact with transcription factors (TFs) using a computational approach with in vitro validation studies. To determine the network of TFs, miRNAs, and target genes involved in sepsis, GEO datasets GSE94717 and GSE131761 were used to identify differentially expressed miRNAs and DEGs. TargetScan and miRWalk databases were used to predict biological targets that overlap with the identified DEGs of differentially expressed miRNAs. The TransmiR database was used to predict the differential miRNA TFs that overlap with the identified DEGs. The TF-miRNA-mRNA network was constructed and visualized. Finally, qRT-PCR was used to verify the expression of TFs and miRNA in HUVECs. Between the healthy and sepsis groups, there were 146 upregulated and 98 downregulated DEGs in the GSE131761 dataset, and there were 1 upregulated and 183 downregulated DEMs in the GSE94717 dataset. A regulatory network of the TF-miRna target genes was established. According to the experimental results, RUNX3 was found to be downregulated while MAPK14 was upregulated, which corroborates the result of the computational expression analysis. In a HUVECs model, miR-19b-1-5p and miR-5009-5p were found to be significantly downregulated. Other TFs and miRNAs did not correlate with our bioinformatics expression analysis. We constructed a TF-miRNA-target gene regulatory network and identified potential treatment targets RUNX3, MAPK14, miR-19b-1-5p, and miR-5009-5p. This information provides an initial basis for understanding the complex sepsis regulatory mechanisms.
- 24 March 2022
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 22 (4) , 481-489
Open AccessIdentification of the TF-miRNA-mRNA co-regulatory networks involved in sepsis
Sepsis is a life-threatening medical condition caused by a dysregulated host response to infection. Recent studies have found that the expression of miRNAs is associated with the pathogenesis of sepsis and septic shock. Our study aimed to reveal which miRNAs may be involved in the dysregulated immune response in sepsis and how these miRNAs interact with transcription factors (TFs) using a computational approach with in vitro validation studies. To determine the network of TFs, miRNAs, and target genes involved in sepsis, GEO datasets GSE94717 and GSE131761 were used to identify differentially expressed miRNAs and DEGs. TargetScan and miRWalk databases were used to predict biological targets that overlap with the identified DEGs of differentially expressed miRNAs. The TransmiR database was used to predict the differential miRNA TFs that overlap with the identified DEGs. The TF-miRNA-mRNA network was constructed and visualized. Finally, qRT-PCR was used to verify the expression of TFs and miRNA in HUVECs. Between the healthy and sepsis groups, there were 146 upregulated and 98 downregulated DEGs in the GSE131761 dataset, and there were 1 upregulated and 183 downregulated DEMs in the GSE94717 dataset. A regulatory network of the TF-miRna target genes was established. According to the experimental results, RUNX3 was found to be downregulated while MAPK14 was upregulated, which corroborates the result of the computational expression analysis. In a HUVECs model, miR-19b-1-5p and miR-5009-5p were found to be significantly downregulated. Other TFs and miRNAs did not correlate with our bioinformatics expression analysis. We constructed a TF-miRNA-target gene regulatory network and identified potential treatment targets RUNX3, MAPK14, miR-19b-1-5p, and miR-5009-5p. This information provides an initial basis for understanding the complex sepsis regulatory mechanisms.